business

Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history.

MarketWatch · May 6, 2026, 7:25 AM · Also reported by 4 other sources

Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.

Read full story on MarketWatch → More top stories

Also covered by

Financial Times Novo Nordisk lifts forecasts after strong demand for Wegovy weight-loss pill CNBC Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance Bloomberg Markets Novo Raises Forecast as Wegovy Pill Fuels Sales Investing.com Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares surge

Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history.

Also covered by

More in business